Recruiting studies: Neoplasm Prostate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The PROSECCA Study, Answering New Questions in Prostate Cancer
Phase N/A · 1 location(s) · University of Edinburgh · NCT06714630 Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Pro
Phase 2 · 3 location(s) · University of Washington · NCT06526299 A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Pro
Phase 1/Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07198633 Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Canc
Phase N/A · 26 location(s) · AstraZeneca · NCT07052578 Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NA · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT07436078 A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer
NA · 1 location(s) · Chinese University of Hong Kong · NCT06262633 Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer
NA · 1 location(s) · University Health Network, Toronto · NCT06335914 An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · 147 location(s) · Novartis Pharmaceuticals · NCT05939414 Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostat
Phase 2 · 3 location(s) · Martha Mims · NCT03833921 Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study
Phase N/A · 1 location(s) · University of Limerick · NCT07605936 Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prost
NA · 1 location(s) · German Oncology Center, Cyprus · NCT07568613 Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
Phase 4 · 3 location(s) · Ottawa Hospital Research Institute · NCT07252726 Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Phase 2 · 1 location(s) · University of Utah · NCT05168618 Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
Phase 2 · 3 location(s) · Peter MacCallum Cancer Centre, Australia · NCT05560659 The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy
NA · 1 location(s) · The Netherlands Cancer Institute · NCT05109910 Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT06738303 Prostate Cancer Genetic Risk Evaluation and Screening Study
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT05129605 RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
NA · 1 location(s) · Cedars-Sinai Medical Center · NCT06856694 Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
Phase N/A · 1 location(s) · Guangxi Medical University · NCT07614256 A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
EARLY_Phase 1 · 1 location(s) · Edwin Posadas, MD · NCT06888102 MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06954337 Comprehensive Assessment of Cancer Theranostic Response
NA · 2 location(s) · AIQ Solutions · NCT06815354 Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
NA · 2 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT06046131 Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Ca
Phase 3 · 1 location(s) · Association Pour La Recherche des Thérapeutiques Innovantes · NCT05116475 A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Phase 1/Phase 2 · 15 location(s) · Phanes Therapeutics · NCT05652686 A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Phase 1/Phase 2 · 24 location(s) · DualityBio Inc. · NCT05785741 High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Phase 2 · 17 location(s) · VA Office of Research and Development · NCT05011383 A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Jiangsu Hansoh Pharmaceutical Co., Ltd. · NCT05740956 A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer
Phase 1/Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07689656 Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT06202248

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →